RT @jvillacastin: Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These res…
RT @ernestocardio: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/OoYzK3crl9 @torresviera @igormorr @drjara…
RT @jvillacastin: Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These res…
RT @jvillacastin: Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These res…
RT @ernestocardio: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/OoYzK3crl9 @torresviera @igormorr @drjara…
RT @jvillacastin: Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These res…
RT @ernestocardio: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/OoYzK3crl9 @torresviera @igormorr @drjara…
RT @jvillacastin: Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These res…
RT @jvillacastin: Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These res…
RT @jvillacastin: Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These res…
Waiting4 a cell/molecular model, more epid studies we need
RT @ernestocardio: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/OoYzK3crl9 @torresviera @igormorr @drjara…
RT @jvillacastin: Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These res…
RT @ernestocardio: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/OoYzK3crl9 @torresviera @igormorr @drjara…
RT @ernestocardio: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/OoYzK3crl9 @torresviera @igormorr @drjara…
RT @ernestocardio: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/OoYzK3crl9 @torresviera @igormorr @drjara…
RT @ernestocardio: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/OoYzK3crl9 @torresviera @igormorr @drjara…
RT @ernestocardio: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/OoYzK3crl9 @torresviera @igormorr @drjara…
RT @ernestocardio: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/OoYzK3crl9 @torresviera @igormorr @drjara…
RT @jvillacastin: Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These res…
RT @ernestocardio: Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/OoYzK3crl9 @torresviera @igormorr @drjara…
Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/OoYzK3crl9 @torresviera @igormorr @drjarayg @jstragazue @recetario1 @Lguevaramath @emartinezgmg @mencardio @DrPontecarlosi @vic_pallares @jpcostabel @gonzaeperez @DrRaulvillar @
RT @jvillacastin: Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These res…
RT @jvillacastin: Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These res…
Habrá q ir viendo.... En espera de nuevos estudios
RT @jvillacastin: Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These res…
RT @jvillacastin: Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These res…
Studies have linked fluoroquinolones (FQs) to cardiac adverse events, including aortic dissection and aneurysm. These results show that the risk of aortic and mitral regurgitation is highest with current use of oral FQs followed by recent use. No past use.
RT @SouthAfricanASP: Time for oral fluoroquinolones to go with the flow (or perhaps against it, depending on damage done)? https://t.co/W4J…
RT @HadyLichaaMD: Potential BIG NEWS! A little hint of AR & MR 2dary to Fluoroquinolones is a big deal! Millions of Rx/yr. Pathophys likely…
RT @HadyLichaaMD: Potential BIG NEWS! A little hint of AR & MR 2dary to Fluoroquinolones is a big deal! Millions of Rx/yr. Pathophys likely…
RT @HadyLichaaMD: Potential BIG NEWS! A little hint of AR & MR 2dary to Fluoroquinolones is a big deal! Millions of Rx/yr. Pathophys likely…
Potential BIG NEWS! A little hint of AR & MR 2dary to Fluoroquinolones is a big deal! Millions of Rx/yr. Pathophys likely collagen mediated. Wish we had enough research $ to test the effect of collagen supplementation @iamritu @FusterValentin @JACCJour
RT @37phoenix: キノロンの使用は大動脈弁・僧帽弁閉鎖不全症のリスク上昇と関連する。J Am Coll Cardiol. 2019;74:1444. PMID: 31514945 https://t.co/7bR9vkPQ4F
RT @37phoenix: キノロンの使用は大動脈弁・僧帽弁閉鎖不全症のリスク上昇と関連する。J Am Coll Cardiol. 2019;74:1444. PMID: 31514945 https://t.co/7bR9vkPQ4F
RT @37phoenix: キノロンの使用は大動脈弁・僧帽弁閉鎖不全症のリスク上昇と関連する。J Am Coll Cardiol. 2019;74:1444. PMID: 31514945 https://t.co/7bR9vkPQ4F
キノロンの使用は大動脈弁・僧帽弁閉鎖不全症のリスク上昇と関連する。J Am Coll Cardiol. 2019;74:1444. PMID: 31514945 https://t.co/7bR9vkPQ4F
RT @MarahClareMD: Be careful when prescribing!!! We as urologists should be well versed in the potentially *serious* risks of our most comm…
RT @MarahClareMD: Be careful when prescribing!!! We as urologists should be well versed in the potentially *serious* risks of our most comm…
Be careful when prescribing!!! We as urologists should be well versed in the potentially *serious* risks of our most commonly used antimicrobials! 💊💉 #antibiotic #antimicrobial #medicationrisk #urology https://t.co/nNb99bUGP8
A new study warns that side effects of Avelox, Levaquin, Cipro and other fluoroquinolone antibiotics may more than double the risk of aortic and mitral regurgitation in users, which can increase the risk of heart failure. https://t.co/jB3YZNX1iP
RT @DrugwatchTerry: A new study ties fluoroquinolone #antibiotics to #heart valve problems. via @nytimes https://t.co/FGUKpG7h2q Read the s…
RT @DrugwatchTerry: A new study ties fluoroquinolone #antibiotics to #heart valve problems. via @nytimes https://t.co/FGUKpG7h2q Read the s…
A new study ties fluoroquinolone #antibiotics to #heart valve problems. via @nytimes https://t.co/FGUKpG7h2q Read the study from @ACCinTouch https://t.co/z1bWSkHaDp more about #cipro & other fluoros @Drug_watch https://t.co/cHPzk8l5R8 https://t.co/9lhG
8/9 2019 puede estar asociado su uso a riesgo de valvulopatía aortica y mitral. https://t.co/rureb9cyN4 https://t.co/mrD6zIO5ph
Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/KlGt7f0KIe
RT @VictorDayan1: Uso actual y reciente de fluorquinolonas se asocia a mayor riesgo de insuficiencia mitral y aortica https://t.co/1bn2jIXD…
RT @SCCMPresident: Another area of concern for fluoroquinolone use and the possible associaton with risk of aortic and mitral regurgitatio…
https://t.co/06lBELbW28 フルオロキノロン(FQ)と大動脈弁逆流や僧帽弁逆流との関連を調べた後ろ向き研究 結果はdisproportionality analysis でのオッズ比は1.45[1.20-1.77]であった。アモキシシリンやアジスロマイシンとの比較では、それぞれ2.40[1.82-3.16}と1.75[1.34-2.29]だった。 #当麻_感染
RT @CollignonPeter: Yet another reason to not use too much cipro. It damages your heart valves. The risk of aortic and mitral regurgitation…
RT @CollignonPeter: Yet another reason to not use too much cipro. It damages your heart valves. The risk of aortic and mitral regurgitation…
RT @CollignonPeter: Yet another reason to not use too much cipro. It damages your heart valves. The risk of aortic and mitral regurgitation…
@phellinckx @IDSAInfo @ICHEJournal @SHEA_Epi @SIDPharm @accpinfdprn @jonotter @eliowa @IDstewardship @blandman19 @CDC_NCEZID @CDCgov @TAEscmid @CHUVLausanne Add this NEW one 🔥🔥 New data in @JACCJournals has also linked FQ use with aortic and mitral regurgi
RT @alfonso_casi: Fluoroquinolonas orales y riesgo de insuficiencia mitral y aórtica. Hasta mejorar el conocimiento de esta asociación, se…
RT @SouthAfricanASP: Time for oral fluoroquinolones to go with the flow (or perhaps against it, depending on damage done)? https://t.co/W4J…
RT @Yuki_Sahashi: これ、なんなんかな。キノロンでAR悪化リスク?統計学的な問題? 長期キノロンってそんなにいないから問題ではない? いつか読む。#jacc Oral Fluoroquinolones and Risk of Mitral and Aortic…
RT @SouthAfricanASP: Time for oral fluoroquinolones to go with the flow (or perhaps against it, depending on damage done)? https://t.co/W4J…
RT @SouthAfricanASP: Time for oral fluoroquinolones to go with the flow (or perhaps against it, depending on damage done)? https://t.co/W4J…
RT @Theriaque_CNHIM: #fluoroquinolones. Le risque de rupture tendineuse est connu ...... le même mécanisme peut entrainer des effets cardia…
RT @SouthAfricanASP: Time for oral fluoroquinolones to go with the flow (or perhaps against it, depending on damage done)? https://t.co/W4J…
Time for oral fluoroquinolones to go with the flow (or perhaps against it, depending on damage done)? https://t.co/W4JWToeJ1N @ABPreservation @AntibioticLeeds @CIDRAP_ASP
Yet another reason to not use too much cipro. It damages your heart valves. The risk of aortic and mitral regurgitation is much higher in those who have taken cipro like antibiotics and is highest with current use followed by recent use. https://t.co/3GROm
RT @SCCMPresident: Another area of concern for fluoroquinolone use and the possible associaton with risk of aortic and mitral regurgitatio…
RT @SCCMPresident: Another area of concern for fluoroquinolone use and the possible associaton with risk of aortic and mitral regurgitatio…
Study: Current users of #fluoroquinolone antibiotics, such as Ciprofloxacin or #Cipro, face 2.4x greater risk of developing aortic and mitral regurgitation (blood backflows into the heart), compared to #patients who take #amoxicillin. #JACC https://t.co/y4
RT @SCCMPresident: Another area of concern for fluoroquinolone use and the possible associaton with risk of aortic and mitral regurgitatio…
RT @SCCMPresident: Another area of concern for fluoroquinolone use and the possible associaton with risk of aortic and mitral regurgitatio…
RT @SCCMPresident: Another area of concern for fluoroquinolone use and the possible associaton with risk of aortic and mitral regurgitatio…
RT @SCCMPresident: Another area of concern for fluoroquinolone use and the possible associaton with risk of aortic and mitral regurgitatio…
RT @SCCMPresident: Another area of concern for fluoroquinolone use and the possible associaton with risk of aortic and mitral regurgitatio…
RT @SCCMPresident: Another area of concern for fluoroquinolone use and the possible associaton with risk of aortic and mitral regurgitatio…
Another area of concern for fluoroquinolone use and the possible associaton with risk of aortic and mitral regurgitation. @SCCM https://t.co/HSEsPoLDlH
RT @pukears: This is a good question. Maybe people need to feel more comfortable w alternatives w slightly less bioavailability? Can we add…
RT @limbsandlungs: We have been using a lot of oral FQ to avoid PICCs. How do we compare risks associated with oral FQ to risks of let's da…
Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/ww26jjAzef
Interesting as a fluoroquinolones victim (Achilles tendinopathy) 😬 Linked to aortic dissection and aneurysm New data show the risk of aortic and mitral regurgitation is highest with current use followed by recent use No risk with past use @JACCjournals htt
RT @AtulPathak31: Current and recent use of Oral Fluoroquinolones increase Risk of Mitral and Aortic Regurgitation. After aortic dissection…
This is a good question. Maybe people need to feel more comfortable w alternatives w slightly less bioavailability? Can we add that into the calculator?
Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/ZGMeBB4DvG
We have been using a lot of oral FQ to avoid PICCs. How do we compare risks associated with oral FQ to risks of let's day PICC + ceftriaxone? Asking for a friend: can you calculate number needed to harm based on a case-control study? https://t.co/uECy23cR
RT @hcg_md: Oral Fluoroquinolones and Risk of Valvular Disease - “Fluoroquinolones held a significant 45% higher likelihood of valvular reg…
不整脈→QT延長,心室性頻脈にガチフロキサシン(GFLX)は慎重投与+糖尿病禁忌。スパルフロキサシン(SPFX)→QT延長へは禁忌•心毒性•心室頻脈有り。心臓•循環器機能障害←パズフロキサシン(PZFX)注は慎重に→水分•Na貯留。重症筋無力症←シプロフロキサシン(CPFX)→悪化。マクロライドにQT延長作用有。
RT @serotonin_nin: シプロフロキサシンなどのフルオロキノロン系抗生物質は使用から30日以内だと、心臓に血液が逆流する大動脈弁および僧帽弁逆流を発症するリスクが2.4倍高くするという論文が。 不適切な抗生物質の使用は耐性菌と心臓病の両方のリスクを引き上げる行為…
RT @serotonin_nin: シプロフロキサシンなどのフルオロキノロン系抗生物質は使用から30日以内だと、心臓に血液が逆流する大動脈弁および僧帽弁逆流を発症するリスクが2.4倍高くするという論文が。 不適切な抗生物質の使用は耐性菌と心臓病の両方のリスクを引き上げる行為…
シプロフロキサシンなどのフルオロキノロン系抗生物質は使用から30日以内だと、心臓に血液が逆流する大動脈弁および僧帽弁逆流を発症するリスクが2.4倍高くするという論文が。 不適切な抗生物質の使用は耐性菌と心臓病の両方のリスクを引き上げる行為だそうです🍀 https://t.co/vIUyMtccbw
キノロンの副作用についてもっと明らかにされていくだろう。自分の経験上も結合組織へのダメージが相当にあるのではないかと思っている。私は必須の症例以外にはキノロンは処方しない。結核も多いし。 Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation https://t.co/SJIA4Tsh6V
Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation | JACC: Journal of the American College of Cardiology https://t.co/fBZNTZD6gq
Oral Fluoroquinolones and Risk of Mitral and Aortic Regurgitation | JACC: Journal of the American College of Cardiology https://t.co/vbQtgfmH13
Oral Fluoroquinolones and Risk of Valvular Disease - “Fluoroquinolones held a significant 45% higher likelihood of valvular regurgitation events reported to the FDA Adverse Events Reporting Systems (FAERS) than did other drugs from 2004 to 2018” https://t.
RT @CiaConnell: Current fluoroquinolone use linked to increased rates of aortic and mitral regurgitation in @US_FDA database case-control…
1st concerns re: association of aortic aneurysm and dissection and now questions re: aortic and mitral valve regurgitation with fluoroquinolone use- here in @JACCJournals https://t.co/mDmzLeWyCM https://t.co/mmCQWfAFA3
Current fluoroquinolone use linked to increased rates of aortic and mitral regurgitation in @US_FDA database case-control study. Postulated mechanism: FQ impact on connective tissue and collagen. Watch this space... @JACCJournals #cardiotwitter https://t
RT @alfonso_casi: Fluoroquinolonas orales y riesgo de insuficiencia mitral y aórtica. Hasta mejorar el conocimiento de esta asociación, se…
RT @alfonso_casi: Fluoroquinolonas orales y riesgo de insuficiencia mitral y aórtica. Hasta mejorar el conocimiento de esta asociación, se…